GlassScriptPhysician profile
Lucy Huo
NPI 1851959522
$1,496.43
in general payments reported to CMS, 2019-2025
19 companies · $486 in 2025
The $486 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $395 · 2024: $615 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,496.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $248.24 | 2023-2025 | |
| Lilly USA, LLC | $192.04 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $169.27 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $135.61 | 2023-2025 | Veozah, Myrbetriq |
| Glaxosmithkline, LLC. | $134.02 | 2023-2025 | Shingrix, Arexvy, Bexsero |
| Astrazeneca Pharmaceuticals LP | $102.07 | 2023-2024 | Farxiga, Airsupra, Breztri |
| Merck Sharp & Dohme LLC | $83.93 | 2023-2024 | Dificid, Gardasil, Capvaxive |
| Amgen INC. | $79.42 | 2024-2025 | Otezla, Repatha, Otezla |
| Dexcom, INC. | $66.62 | 2023-2025 | Dexcom G6 Transmitter |
| Idorsia Pharmaceuticals US INC | $59.96 | 2023-2024 | Quviviq |
| Organon LLC | $38.65 | 2024 | |
| Renalytix Ai, INC. | $35.30 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Abbott Laboratories | $30.07 | 2023-2025 | Infinity, Freestyle Libre 3 |
| Tandem Diabetes Care, INC. | $23.95 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Sanofi-Aventis U.S. LLC | $23.93 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $20.90 | 2023 | Ztlido |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.71 | 2024 | Jardiance |
| Dynavax Technologies Corporation | $17.62 | 2025 | Heplisav-B |
| Exact Sciences Corporation | $17.12 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucy Huo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.